Your browser doesn't support javascript.
loading
Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism.
Bellini, E; Pia, A; Brizzi, M P; Tampellini, M; Torta, M; Terzolo, M; Dogliotti, L; Berruti, A.
Afiliação
  • Bellini E; Department of Clinical and Biological Sciences; Department of Medical Oncology and.
  • Pia A; Department of Clinical and Biological Sciences; Department of Internal Medicine, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy.
  • Brizzi MP; Department of Clinical and Biological Sciences; Department of Medical Oncology and.
  • Tampellini M; Department of Medical Oncology and.
  • Torta M; Department of Clinical and Biological Sciences; Department of Medical Oncology and.
  • Terzolo M; Department of Clinical and Biological Sciences; Department of Internal Medicine, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy.
  • Dogliotti L; Department of Clinical and Biological Sciences; Department of Medical Oncology and.
  • Berruti A; Department of Medical Oncology and. Electronic address: alfredo.berruti@gmail.com.
Ann Oncol ; 22(4): 988-990, 2011 Apr.
Article em En | MEDLINE | ID: mdl-21321087
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Benzenossulfonatos / Hipofosfatemia / Fatores de Crescimento de Fibroblastos / Antineoplásicos Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2011 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Benzenossulfonatos / Hipofosfatemia / Fatores de Crescimento de Fibroblastos / Antineoplásicos Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2011 Tipo de documento: Article